3.31
-0.01 (-0.3%)
-0.01 (-0.3%)
Upgrade to Real-Time
Premarket
Low
3.02
High
46.4999
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Odonate Therapeutics Inc | ODT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.01 | -0.3% | 3.31 | 07:36:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.32 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.26 | 3.31 | 0.05 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 11 | 639 | 578,214 | 3.02 - 46.4999 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:15:28 | 1 | $ 3.31 | USD |
Odonate Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 127.57M | 38.54M | 19.80M | $ - | $ - | -4.09 | -5.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Odonate Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ODT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.41 | 3.47 | 3.18 | 3.28 | 923,410 | -0.10 | -2.93% |
| 1 Month | 3.03 | 4.97 | 3.02 | 3.77 | 10,937,276 | 0.28 | 9.24% |
| 3 Months | 24.57 | 28.41 | 3.02 | 4.55 | 4,355,475 | -21.26 | -86.53% |
| 6 Months | 16.20 | 28.41 | 3.02 | 5.85 | 2,329,747 | -12.89 | -79.57% |
| 1 Year | 28.32 | 46.4999 | 3.02 | 7.38 | 1,268,194 | -25.01 | -88.31% |
| 3 Years | 20.72 | 46.4999 | 3.02 | 9.38 | 475,759 | -17.41 | -84.03% |
| 5 Years | 23.00 | 46.4999 | 3.02 | 9.67 | 433,264 | -19.69 | -85.61% |
Odonate Therapeutics Description
| Odonate Therapeutics Inc is a US-based pharmaceutical company that is engaged in the development of therapeutics which improves and extends the lives of patients with cancer. The company mainly focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs, taxanes, which are widely used in the treatment of cancer including breast cancer. The key product of the company is Tesetaxel which is chemotherapy for oral administration with a low pill burden for various types of cancers. |
